Lipoprotein(a) Binds to Recombinant Nontypeable Haemophilus influenzae Aspartase
American Journal of Clinical and Experimental Medicine
Volume 3, Issue 5, September 2015, Pages: 314-321
Received: Dec. 3, 2015; Published: Dec. 4, 2015
Views 3122      Downloads 46
Authors
Wenlong Li, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Liping Xu, College of Basic Medicine, Inner Mongolia Medical University, Huhhot, China
Yakun Zhang, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Wencheng Bai, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Lulei Zhou, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Yuxin Li, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Na Liu, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Ling Liu, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China
Runlin Han, Research Center of Plasma Lipoprotein Immunology, Inner Mongolia Agricultural University, Huhhot, China; Key Laboratory of Animal Clinic Diagnosis and Treatment (Ministry of Agriculture of the People’s Republic of China), Inner Mongolia Agricultural University, Huhhot, China
Article Tools
Follow on us
Abstract
The respiratory pathogen nontypeable Haemophilus influenza (NTHi) can recruit plasminogen (Plg) on the cell surface by its Plg receptor aspartase (ASP) and utilize host Plg and fibrinolytic system to achieve its adherence and immune invasion. Lipoprotein(a) [Lp(a)] consists of one molecule low-density lipoprotein (LDL) and one molecule apolipoprotein(a) [Apo(a)]. Apo(a) shares a high degree of homology with the human Plg, and both of them contain lysine-binding sites (LBS), which enables them to interact with various cell-surface receptors or fibrin(ogen). However, the definite physiological function of Lp(a) remains vague. Here, we present evidence that Lp(a) via its Apo(a) may bind to thePlg receptor ASP. Recombinant aspartase (rASP) and C-terminal lysine-deleted variant of ASP (rASPΔK) were used in the current study. The rASP specifically bound to Lp(a), but rASPΔK did not, indicating that C-terminal lysine residue of rASP was responsible for the interaction. In addition, rASP interacted with Lp(a), but not with LDL, revealing that LBS of Apo(a) was involved in the binding. Our results also showed that Lp(a) could inhibit the binding of Plg to rASP. Plasma Lp(a) might play a role in anti-NTHi infection by binding to its Plg receptor ASP.
Keywords
Lipoprotein(a), Apolipoprotein(a), Nontypeable Haemophilus influenzae, Plasminogen, Recombinant Aspartase
To cite this article
Wenlong Li, Liping Xu, Yakun Zhang, Wencheng Bai, Lulei Zhou, Yuxin Li, Na Liu, Ling Liu, Runlin Han, Lipoprotein(a) Binds to Recombinant Nontypeable Haemophilus influenzae Aspartase, American Journal of Clinical and Experimental Medicine. Vol. 3, No. 5, 2015, pp. 314-321. doi: 10.11648/j.ajcem.20150305.31
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186